Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

JAMA Health Forum

2025-04-25

(Press-News.org) About The Study: This economic evaluation estimates that expanded Medicare coverage for glucagon-like peptide-1 receptor agonists (GLP-1RAs) would increase access and reduce obesity-related comorbidities but impose substantial costs over 10 years. Even with a moderate scenario (5% uptake, 20% adherence, and 30% additional price discount), net spending was still projected to reach $8 billion over a decade, underscoring the need for further price reductions, lower-cost strategies to prevent weight regain, and reductions in spending on low-value care.

Corresponding Author: To contact the corresponding author, David D. Kim, PhD, email david.kim@bsd.uchicago.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamahealthforum.2025.0905)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2025.0905?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=042525

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

END

ELSE PRESS RELEASES FROM THIS DATE:

State and sociodemographic trends in US cigarette smoking with future projections

2025-04-25

About The Study: The findings of these repeated cross-sectional surveys suggest that the difference in cigarette smoking prevalence between historically high vs low prevalence states will shrink by 2035, primarily from much faster declines among young adults in the traditionally highest prevalence states. Slower prevalence declines among older adults are likely to slow the decline in health consequences in these states. Corresponding Author: To contact the corresponding author, John P. Pierce, PhD, email jppierce@health.ucsd.edu. To access the embargoed study: Visit ...

Young adults drive historic decline in smoking

2025-04-25

Researchers at University of California San Diego found that cigarette smoking continues to decline across the United States, largely driven by young adults. Their study, published in JAMA Network Open on April 25, 2025, reveals that the states with historically high smoking rates have seen the most dramatic declines. However, smoking cessation progress among adults over 50 has been much slower, which could prolong the public health burden of smoking-related diseases and death. “The rapid decline in smoking among young adults is clear evidence that the smoking epidemic will come to an end in our lifetime,” said Matthew ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

2025-04-25

NFCR Congratulates Dr. Robert C. Bast, Jr. on Receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research Rockville, MD — The National Foundation for Cancer Research (NFCR) proudly congratulates Dr. Robert C. Bast, Jr., a pioneering cancer scientist, and NFCR-supported investigator from 2001 to 2018, on being named the 2025 recipient of the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research. Presented by the American Association for Cancer Research (AACR), ...

Chimpanzee stem cells offer new insights into early embryonic development

2025-04-25

Understanding how cells differentiate during early embryonic development is crucial for advancing regenerative medicine and developmental biology. Pluripotent stem cells (PSCs) have been invaluable tools in this field, as they can transform into various cell types in the body and play key roles during early embryonic development. Unfortunately, research on this topic in humans and other primates has long been hampered by ethical constraints and technical limitations. Of particular interest are naive-type PSCs, which represent an earlier developmental state than conventional (or ‘primed’) PSCs and possess enhanced differentiation potential. While human naive PSCs can differentiate ...

This injected protein-like polymer helps tissues heal after a heart attack

2025-04-25

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to encourage tissue repair and promotes survival of heart muscle cells after a heart attack. Researchers tested the therapy in rats and showed that it is effective up to five weeks after injection. The research team, led by bioengineers at the University of California San Diego and chemists at Northwestern University, published ...

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

2025-04-25

FlexTech, an international academic journal (ISSN 2771-1706), jointly published by Tsinghua University Press and Wiley Publishing Group, has officially released its first issue. Supported by Tsinghua University’s State Key Laboratory of Flexible Electronics Technology, the journal aims to serve as a global platform for scholars to advance cutting-edge research and engineering applications in flexible materials, devices, and systems, driving humanity toward an intelligent era. Editor-in-Chief’s Vision: Bridging Humanity, Machines, and the Digital World In his inaugural editorial, Prof. Xue Feng from Tsinghua University, Editor-in-Chief ...

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

2025-04-25

Studies by a growing number of labs have identified neurological health benefits from exposing human volunteers or animal models to light, sound and/or tactile stimulation at the brain’s “gamma” frequency rhythm of 40Hz. In the latest such research at The Picower Institute for Learning and Memory and Alana Down Syndrome Center at MIT, scientists found that 40Hz sensory stimulation improved cognition and circuit connectivity and encouraged the growth of new neurons in mice genetically engineered to model Down syndrome. Li-Huei Tsai, Picower Professor at MIT and senior author of the new study in PLOS ONE, said that the results are encouraging but also cautioned ...

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

2025-04-25

Methyl eugenol (ME), a phenylpropanoid compound found in the essential oils of various aromatic plants, has recently garnered attention due to its significant antioxidant, anticancer, and neuroprotective properties. ME, commonly used in the fragrance and food industries, is also studied for its potential therapeutic effects, particularly in mitigating diseases associated with oxidative stress, such as Alzheimer’s disease, cancers, and ischemic brain injuries. However, despite its therapeutic promise, concerns ...

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

2025-04-25

A research article published by the Shanghai University presented a novel microfluidic chip design with a 3-layer configuration that utilizes a polycarbonate (PC) porous membrane to separate the culture fluid channels from the tissue chambers, featuring flexibly designable multitissue chambers. PC porous membranes act as the capillary in the vertical direction, enabling precise hydrogel patterning and successfully constructing a microfluidic environment suitable for microvascular tissue growth. The new research paper, published on Feb. 28, 2025 in the journal Cyborg and Bionic Systems, presented a flexible and scalable chip that is highly suitable for culturing multiple ...

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

2025-04-25

A new study found that a gene recently recognized as a biomarker for Alzheimer’s disease is actually a cause of it, due to its previously unknown secondary function. Researchers at the University of California San Diego used artificial intelligence to help both unravel this mystery of Alzheimer’s disease and discover a potential treatment that obstructs the gene’s moonlighting role. The research team published their results on April 23 in the journal Cell. About one in nine people aged 65 ...

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: